Rn. Fedorak et al., A NOVEL COLON-SPECIFIC STEROID PRODRUG ENHANCES SODIUM-CHLORIDE ABSORPTION IN RAT COLITIS, American journal of physiology: Gastrointestinal and liver physiology, 32(2), 1995, pp. 210-218
A recently synthesized novel colon-specific dexamethasone prodrug, dex
amethasone-beta-D-glucuronide, delivers efficacious amounts of dexamet
hasone to the colon with limited adrenal suppressive effects. During e
xperimentally induced colitis in rats, the dexamethasone prodrug is si
gnificantly more potent than free dexamethasone in improving colonic f
luid and electrolyte absorptive injury. The present studies examined w
hether the improvement in colonic absorption seen with the prodrug occ
urred as a consequence of alterations in sodium and chloride epithelia
l transport. The efficacy of the dexamethasone prodrug and free dexame
thasone were tested in an acetic acid-induced rat model of colitis. He
aling of the induced colitis was assessed by measuring net colonic flu
id absorption and surface area ulceration. Transmural unidirectional f
luxes of Na-22 and Cl-36 across sheets of colonic mucosa were measured
in Ussing chambers. Treatment of colitis with the prodrug delivered a
sixfold higher concentration of dexamethasone to the colon than did t
reatment with the free drug. The prodrug accelerated healing of coliti
s by returning in vivo colonic fluid absorption to normal and virtuall
y eliminated colonic macroscopic ulceration, whereas the free drug did
not. In vitro transmural fluxes demonstrated that, in addition to rep
air of mucosal integrity, the prodrug enhanced electroneutral sodium c
hloride absorption over and above that seen in control animals or afte
r treatment with the free drug. Both the prodrug and the free drug lim
ited theophylline-mediated net chloride and sodium secretion, an effec
t that would be consistent with the antidiarrheal effect induced by th
ese drugs in vivo. The results suggest that treatment of experimentall
y induced colitis with the novel colon-specific prodrug, dexamethasone
-beta-D-glucuronide, has distinct mucosal healing and antidiarrheal ad
vantages over administration of its parent, free dexamethasone. Specif
ically, dexamethasone prodrug treatment enhances sodium chloride absor
ptive effects and limits adenosine 3',5'-cyclic monophosphate-mediated
secretion of colonic epithelia.